Shanghai Haohai Biological Technology Co., Ltd. (SHA:688366)

Market Cap	9.52B -19.5%
Revenue (ttm)	2.50B -8.2%
Net Income	384.21M -10.7%
EPS	1.65 -37.8%
Shares Out	n/a
PE Ratio	24.77
Forward PE	n/a
Dividend	1.00 (2.17%)
Ex-Dividend Date	Oct 16, 2025

Volume	293,394
Average Volume	650,667
Open	46.00
Previous Close	45.86
Day's Range	45.81 - 46.16
52-Week Range	43.65 - 65.00
Beta	0.54
RSI	45.49
Earnings Date	Mar 21, 2026

About SHA:688366

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyaluronate gel, anti-adhesion, and burn wound related products. In addition, it provides injectors, scalpels, suture needles and other products. Further, ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,156
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688366

Financial Performance

In 2024, SHA:688366's revenue was 2.68 billion, an increase of 1.70% compared to the previous year's 2.63 billion. Earnings were 420.45 million, an increase of 1.04%.